Biopsy Troubles

A personalized medicine study has run into an unexpected issue: tumor biopsies that aren't good enough to undergo genetic analysis, Stat News reports.

Between 10 percent and 20 percent of the needle biopsies collected for the National Cancer Institute MATCH trial, which began in August, are of poor quality and contain few tumor cells, it adds.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.